Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CHNG Stock Summary
In the News
CHNG Financial details
Company Rating
Buy
Market Cap
0
Income
-122.17M
Revenue
3.5B
Book val./share
10.08
Cash/share
0.29
Dividend
-
Dividend %
-
Employees
14K
Optionable
No
Shortable
Yes
Earnings
03 Nov 2022
P/E
-146.46
Forward P/E
-
PEG
-210.09
P/S
-
P/B
2.73
P/C
-
P/FCF
-
Quick Ratio
0.87
Current Ratio
1.23
Debt / Equity
1.39
LT Debt / Equity
1.38
-
-
EPS (TTM)
-0.37
EPS next Y
-
EPS next Q
-
EPS this Y
37.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-3.88%
EPS Q/Q
120.34%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.03%
Inst Trans
0%
ROA
-1%
ROE
-2%
ROC
0.01%
Gross Margin
100%
Oper. Margin
7%
Profit Margin
-3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
18.97-27.59
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.01582
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
CHNG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 1.44 | 9.63 | 10.74 | |
Net income per share | 0.52 | -0.44 | -6.92 | -0.35 | -0.48 | |
Operating cash flow per share | 0 | 0.03 | -1.12 | 1.83 | 2.15 | |
Free cash flow per share | 0 | 0.03 | -1.22 | 1.06 | 1.3 | |
Cash per share | 0 | 0.03 | 3 | 0.35 | 0.78 | |
Book value per share | 9.94 | 9.57 | 23.98 | 10.14 | 10.11 | |
Tangible book value per share | 9.94 | 9.57 | -35.59 | -15.72 | -14 | |
Share holders equity per share | 9.94 | 9.57 | 23.98 | 10.14 | 10.11 | |
Interest debt per share | 0 | 0 | 36.54 | 15.71 | 15.12 | |
Market cap | 1.77B | 1.77B | 1.37B | 7.09B | 7.06B | |
Enterprise value | 1.77B | 1.77B | 5.95B | 11.77B | 11.47B | |
P/E ratio | 29.12 | -34.13 | -1.44 | -63.18 | -45.68 | |
Price to sales ratio | 0 | 0 | 6.95 | 2.29 | 2.03 | |
POCF ratio | 0 | 520.83 | -8.89 | 12.09 | 10.14 | |
PFCF ratio | 0 | 520.83 | -8.2 | 20.86 | 16.79 | |
P/B Ratio | 1.51 | 1.57 | 0.42 | 2.18 | 2.16 | |
PTB ratio | 1.51 | 1.57 | 0.42 | 2.18 | 2.16 | |
EV to sales | 0 | 0 | 30.22 | 3.81 | 3.3 | |
Enterprise value over EBITDA | -30.26 | -25.09 | -5.7 | 17.05 | 12.65 | |
EV to operating cash flow | 0 | 519.83 | -38.64 | 20.08 | 16.47 | |
EV to free cash flow | 0 | 519.83 | -35.63 | 34.63 | 27.28 | |
Earnings yield | 0.03 | -0.03 | -0.69 | -0.02 | -0.02 | |
Free cash flow yield | 0 | 0 | -0.12 | 0.05 | 0.06 | |
Debt to equity | 0 | 0 | 1.52 | 1.47 | 1.42 | |
Debt to assets | 0 | 0 | 0.49 | 0.47 | 0.47 | |
Net debt to EBITDA | 0 | 0.05 | -4.39 | 6.78 | 4.86 | |
Current ratio | 1 | 0.88 | 1.32 | 1.07 | 1.22 | |
Interest coverage | 0 | 0 | -42.71 | 0.41 | 0.96 | |
Income quality | 0 | -0.07 | 0.16 | -5.22 | -12.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0.06 | 0.07 | 0.08 | |
Intangibles to total assets | 0 | 0 | 0.81 | 0.82 | 0.79 | |
Capex to operating cash flow | 0 | 0 | 0.08 | -0.42 | -0.4 | |
Capex to revenue | 0 | 0 | -0.07 | -0.08 | -0.08 | |
Capex to depreciation | 0 | 0 | -0.42 | -0.42 | -0.41 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.02 | 0.03 | |
Graham number | 10.74 | 9.73 | 61.09 | 8.93 | 10.42 | |
ROIC | 0 | 0 | -0.07 | 0.01 | 0.04 | |
Return on tangible assets | 0.04 | -0.04 | -0.49 | -0.06 | -0.07 | |
Graham Net | -1.57 | -1.36 | -42.02 | -19.01 | -18.1 | |
Working capital | 0 | -780K | 341.39M | 71.71M | 233.24M | |
Tangible asset value | 1.18B | 1.13B | -4.88B | -5.04B | -4.54B | |
Net current asset value | -181.3M | -160.77M | -5.42B | -5.74B | -5.34B | |
Invested capital | 0 | 0 | 1.52 | 1.47 | 1.42 | |
Average receivables | 0 | 9.14M | 437.72M | 869.38M | 792.8M | |
Average payables | 0 | 0 | 34.08M | 62.81M | 80.86M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 1.62K | 102.22 | 75.51 | |
Days payables outstanding | 0 | 0 | 295.98 | 13.69 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0.23 | 3.57 | 4.83 | |
Payables turnover | 0 | 0 | 1.23 | 26.66 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | -0.05 | -0.29 | -0.03 | -0.05 | |
Capex per share | 0 | 0 | -0.09 | -0.77 | -0.85 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q1
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.69 | 2.55 | 2.67 | 2.78 | 2.71 | |
Net income per share | -0.01 | -0.11 | -0.08 | -0.06 | -0.13 | |
Operating cash flow per share | 0.34 | 0.47 | 0.55 | 2.11 | 0.26 | |
Free cash flow per share | 0.14 | 0.28 | 0.34 | 1.27 | 0.01 | |
Cash per share | 0.34 | 0.25 | 0.3 | 0.76 | 0.29 | |
Book value per share | 10.12 | 10.01 | 10.01 | 9.9 | 10.08 | |
Tangible book value per share | -15.23 | -14.84 | -14.45 | -13.71 | -13.47 | |
Share holders equity per share | 10.12 | 10.01 | 10.01 | 9.9 | 10.08 | |
Interest debt per share | 15.24 | 14.85 | 14.57 | 14.27 | 14.14 | |
Market cap | 7.43B | 6.79B | 6.94B | 7.21B | 7.53B | |
Enterprise value | 12.18B | 11.46B | 11.51B | 11.62B | 12B | |
P/E ratio | -515.36 | -46.6 | -70.85 | -92.43 | -45.05 | |
Price to sales ratio | 8.56 | 8.21 | 8.01 | 7.84 | 8.51 | |
POCF ratio | 67.49 | 44.87 | 39.08 | 10.36 | 90.39 | |
PFCF ratio | 168.51 | 75.05 | 62.12 | 17.16 | 1.99K | |
P/B Ratio | 2.28 | 2.09 | 2.14 | 2.2 | 2.29 | |
PTB ratio | 2.28 | 2.09 | 2.14 | 2.2 | 2.29 | |
EV to sales | 14.03 | 13.86 | 13.29 | 12.63 | 13.56 | |
Enterprise value over EBITDA | 56.31 | 67.15 | 58.85 | 15.32 | 55.87 | |
EV to operating cash flow | 110.61 | 75.76 | 64.86 | 16.69 | 143.99 | |
EV to free cash flow | 276.15 | 126.73 | 103.09 | 27.65 | 3.17K | |
Earnings yield | 0 | -0.01 | 0 | 0 | -0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.06 | 0 | |
Debt to equity | 1.49 | 1.47 | 1.44 | 1.42 | 1.39 | |
Debt to assets | 0.48 | 0.48 | 0.47 | 0.47 | 0.47 | |
Net debt to EBITDA | 21.95 | 27.38 | 23.39 | 5.82 | 20.8 | |
Current ratio | 1.12 | 1.1 | 1.11 | 1.22 | 1.23 | |
Interest coverage | 0.74 | 0.19 | 0.41 | 1.36 | 0.76 | |
Income quality | -30.54 | -4.15 | -7.25 | 98.23 | -3.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
Intangibles to total assets | 0.82 | 0.82 | 0.81 | 0.79 | 0.8 | |
Capex to operating cash flow | -0.6 | -0.4 | -0.37 | -0.4 | -0.95 | |
Capex to revenue | -0.08 | -0.07 | -0.08 | -0.3 | -0.09 | |
Capex to depreciation | -0.39 | -0.37 | -0.38 | -0.41 | -0.46 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.03 | 0.1 | 0.06 | |
Graham number | 1.6 | 5.03 | 4.12 | 3.62 | 5.39 | |
ROIC | 0 | 0 | 0 | 0.03 | 0.01 | |
Return on tangible assets | 0 | -0.02 | -0.01 | -0.01 | -0.02 | |
Graham Net | -18.6 | -18.21 | -17.95 | -17.73 | -17.5 | |
Working capital | 122.06M | 97.17M | 110.16M | 233.24M | 213.6M | |
Tangible asset value | -4.91B | -4.81B | -4.69B | -4.54B | -4.4B | |
Net current asset value | -5.63B | -5.54B | -5.45B | -5.34B | -5.2B | |
Invested capital | 1.49 | 1.47 | 1.44 | 1.42 | 1.39 | |
Average receivables | 872.03M | 855.59M | 870.31M | 814.07M | 718.9M | |
Average payables | 75.05M | 78.7M | 76.12M | 95.88M | 94.74M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 91.11 | 90.64 | 94.36 | 70.44 | 73.03 | |
Days payables outstanding | 20.68 | 14.6 | 19.25 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.99 | 0.99 | 0.95 | 1.28 | 1.23 | |
Payables turnover | 4.35 | 6.16 | 4.68 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex per share | -0.2 | -0.19 | -0.2 | -0.83 | -0.24 |
CHNG Frequently Asked Questions
What is Change Healthcare Inc. stock symbol ?
Change Healthcare Inc. is a US stock , located in Nashville of Tennessee and trading under the symbol CHNG
What is Change Healthcare Inc. stock quote today ?
Change Healthcare Inc. stock price is $- today.
Is Change Healthcare Inc. stock public?
Yes, Change Healthcare Inc. is a publicly traded company.